320
Participants
Start Date
May 31, 2006
Primary Completion Date
November 30, 2006
Study Completion Date
November 30, 2006
sumatriptan succinate/naproxen sodium
placebo
placebo to match
GSK Investigational Site, Plainview
GSK Investigational Site, Albany
GSK Investigational Site, Rochester
GSK Investigational Site, Pittsburgh
GSK Investigational Site, Greensboro
GSK Investigational Site, Greer
GSK Investigational Site, Atlanta
GSK Investigational Site, Miami
GSK Investigational Site, Fort Lauderdale
GSK Investigational Site, Memphis
GSK Investigational Site, Westerville
GSK Investigational Site, Independence
GSK Investigational Site, Cleveland
GSK Investigational Site, Detroit
GSK Investigational Site, St Louis
GSK Investigational Site, Springfield
GSK Investigational Site, Wichita
GSK Investigational Site, Little Rock
GSK Investigational Site, Fort Worth
GSK Investigational Site, San Antonio
GSK Investigational Site, Austin
GSK Investigational Site, Salt Lake City
GSK Investigational Site, Mesa
GSK Investigational Site, Albuquerque
GSK Investigational Site, San Diego
GSK Investigational Site, Newport Beach
GSK Investigational Site, San Francisco
GSK Investigational Site, Fair Oaks
GSK Investigational Site, Eugene
GSK Investigational Site, Wenatchee
GSK Investigational Site, Stamford
GSK Investigational Site, Milford
GSK Investigational Site, North Dartmouth
GSK Investigational Site, Moorestown
Lead Sponsor
GlaxoSmithKline
INDUSTRY